Comparing treatments for chronic low back pain
Innovative Approaches in Managing Chronic Low Back Pain: A Comparative Assessment of Clinical Techniques
This study is testing if a new treatment combining nerve stimulation and platelet-rich plasma can help people with chronic low back pain feel better compared to standard therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | All |
| Sponsor | Iffat Anwar Medical Complex Academic / other |
| Locations | 1 site (Lahore) |
| Trial ID | NCT06453291 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of two treatment approaches for chronic low back pain (CLBP). One group will receive conventional therapy, including NSAIDs and physical therapy, while the other group will undergo a combination of neuromodulation via the dorsal root ganglion and platelet-rich plasma (PRP) therapy. The study aims to determine if the innovative approach of neuromodulation and PRP can provide better pain relief and functional improvement compared to standard treatments. Insights gained from this trial could inform future therapeutic strategies for managing CLBP.
Who should consider this trial
Good fit: Ideal candidates are adults aged 40-60 years with chronic low back pain lasting more than three months.
Not a fit: Patients with comorbidities, severe psychiatric disorders, or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective treatment options for patients suffering from chronic low back pain.
How similar studies have performed: While there have been studies on neuromodulation and PRP therapy separately, this specific combination approach is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 40-60 years. * Diagnosed with chronic low back pain persisting for more than three months. * Willingness to participate and comply with study procedures. * Ability to provide informed consent. Exclusion Criteria: * Comorbidities. * Contagious and Non-Contagious Infections * Known hypersensitivity to study interventions. * Presence of severe psychiatric disorders. * Pregnancy or breastfeeding. * Participation in another clinical trial within the last 30 days.
Where this trial is running
Lahore
- Iffat Anwar Medical Complex — Lahore, Pakistan (Recruiting)
Study contacts
- Principal investigator: Shahzad Anwar, MBBS, DOM — Iffat Anwar Medical Complex, Lahore
- Study coordinator: Shahzad Anwar, MBBS, DOM
- Email: shahzadtirmzi@yahoo.com
- Phone: +923009400049
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.